Liza K. Phillips

Liza K. Phillips

Auto-generated profile, based on publicly available information

Liza K. Phillips

Adelaide Medical School, The University of Adelaide, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2014 in Nature Reviews Endocrinology
Verified
Journal Article
Closed access
LPLiza K. Phillips
Liza K. Phillips
ADAdam M. Deane
Adam M. Deane
KJKaren L Jones
Karen L Jones
CRChris K. Rayner
Chris K. Rayner
Michael HorowitzMichael Horowitz
Michael Horowitz

1 May 2006 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
TLTanya Little
Tanya Little
APAmelia N. Pilichiewicz
Amelia N. Pilichiewicz
ARAntonietta Russo
Antonietta Russo
LPLiza Phillips
Liza Phillips
KJKaren L Jones
Karen L Jones
CFChristine Feinle-Bisset
Christine Feinle-Bisset
The inhibitory action of glucagon-like peptide-1 (GLP-1) on gastric emptying (GE) is likely to be important in mediating its effects on postprandial glycemia, appetite, and gastrointestinal symptoms. The objective of the study was to evaluate the effects of "low" and "high" doses of iv GLP-1 on GE, intragastric meal distribution, glycemia, insulinemia, and appetite. Ten healthy males were studied on 3 d. GE of a solid (ground beef)/liquid (glucose) meal, blood glucose, plasma insulin, glucagon and glucose-dependent insulinotropic peptide, appetite perceptions, and gastrointestinal symptoms were evaluated during iv infusion of: 1) GLP-1 at 0.3 pmol x kg(-1) x min(-1) (GLP-1 0.3); 2) GLP-1 at 0.9 pmol x kg(-1) x min(-1) (GLP-1 0.9); and 3) 0.9% saline. GLP-1 0.3 and 0.9 slowed GE of solid (intragastric retention at t = 100 min; saline: 28 +/- 5%; GLP-1 0.3: 53 +/- 6%; GLP-1 0.9: 58 +/- 7%; P < 0.001) and liquid (time for 50% of the liquid to empty, saline: 28 +/- 2 min; GLP-1 0.3: 42 +/- 7 min; GLP-1 0.9: 50 +/- 9 min; P < 0.001). Both doses of GLP-1 induced gastroparesis in about half the cohort and increased meal retention in the distal stomach (P < 0.05). GLP-1 attenuated the rises in glucose, insulin, and glucose-dependent insulinotropic peptide (P < 0.05). There was an inverse relationship between blood glucose at t = 15 min and the time for 50% of the liquid to empty (r = -0.70, P < 0.001). In healthy subjects exogenous GLP-1 increases meal retention in the distal stomach and, even when administered in a "low" dose, frequently induces "gastroparesis," and the effects of GLP-1 on postprandial glycemia are predictable on the basis of its effect on GE, supporting the concept that GE is a major target mechanism for the clinical use of incretin mimetics.

27 April 2008 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
LPLiza K. Phillips
Liza K. Phillips
JPJohannes B. Prins
Johannes B. Prins

27 September 2016 in Critical Care
Verified
Journal Article
Open access
PDF file
YAYasmine Ali Abdelhamid
Yasmine Ali Abdelhamid
PKPalash Kar
Palash Kar
MFMark E. Finnis
Mark E. Finnis
LPLiza K. Phillips
Liza K. Phillips
MPMark Plummer
Mark Plummer
ADAdam M. Deane
Adam M. Deane
Hyperglycaemia occurs frequently in critically ill patients without diabetes. We conducted a systematic review and meta-analysis to evaluate whether this ‘stress hyperglycaemia’ identifies survivors of critical illness at increased risk of subsequently developing diabetes. We searched the MEDLINE and Embase databases from their inception to February 2016. We included observational studies evaluating adults admitted to the intensive care unit (ICU) who developed stress hyperglycaemia if the researchers reported incident diabetes or prediabetes diagnosed ≥3 months after hospital discharge. Two reviewers independently screened the titles and abstracts of identified studies and evaluated the full text of relevant studies. Data were extracted using pre-defined data fields, and risk of bias was assessed using the Newcastle-Ottawa Scale. Pooled ORs with 95 % CIs for the occurrence of diabetes were calculated using a random-effects model. Four cohort studies provided 2923 participants, including 698 with stress hyperglycaemia and 131 cases of newly diagnosed diabetes. Stress hyperglycaemia was associated with increased risk of incident diabetes (OR 3.48; 95 % CI 2.02–5.98; I 2 = 36.5 %). Studies differed with regard to definitions of stress hyperglycaemia, follow-up and cohorts studied. Stress hyperglycaemia during ICU admission is associated with increased risk of incident diabetes. The strength of this association remains uncertain because of statistical and clinical heterogeneity among the included studies.

1 December 2011 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
LPLiza K. Phillips
Liza K. Phillips
JPJohannes B. Prins
Johannes B. Prins

8 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MPMark Plummer
Mark Plummer
MFMark E. Finnis
Mark E. Finnis
LPLiza K. Phillips
Liza K. Phillips
PKPalash Kar
Palash Kar
SBShailesh Bihari
Shailesh Bihari
ADAdam M. Deane
Adam M. Deane
Stress induced hyperglycemia occurs in critically ill patients who have normal glucose tolerance following resolution of their acute illness. The objective was to evaluate the association between stress induced hyperglycemia and incident diabetes in survivors of critical illness. Retrospective cohort study. All adult patients surviving admission to a public hospital intensive care unit (ICU) in South Australia between 2004 and 2011. Stress induced hyperglycemia was defined as a blood glucose ≥ 11.1 mmol/L (200 mg/dL) within 24 hours of ICU admission. Prevalent diabetes was identified through ICD-10 coding or prior registration with the Australian National Diabetes Service Scheme (NDSS). Incident diabetes was identified as NDSS registration beyond 30 days after hospital discharge until July 2015. The predicted risk of developing diabetes was described as sub-hazard ratios using competing risk regression. Survival was assessed using Cox proportional hazards regression. Stress induced hyperglycemia was identified in 2,883 (17%) of 17,074 patients without diabetes. The incidence of type 2 diabetes following critical illness was 4.8% (821 of 17,074). The risk of diabetes in patients with stress induced hyperglycemia was approximately double that of those without (HR 1.91 (95% CI 1.62, 2.26), p<0.001) and was sustained regardless of age or severity of illness. Stress induced hyperglycemia identifies patients at subsequent risk of incident diabetes.